scispace - formally typeset
M

Melinda Wuest

Researcher at University of Alberta

Publications -  77
Citations -  7267

Melinda Wuest is an academic researcher from University of Alberta. The author has contributed to research in topics: In vivo & Chemistry. The author has an hindex of 18, co-authored 66 publications receiving 4836 citations. Previous affiliations of Melinda Wuest include Cross Cancer Institute.

Papers
More filters
Journal ArticleDOI

In situ click chemistry generation of cyclooxygenase-2 inhibitors

TL;DR: In situ click chemistry is used to develop COX-2 specific inhibitors with high in vivo anti-inflammatory activity, significantly higher than that of widely used selective cyclooxygenase-2 inhibitors.
Journal ArticleDOI

Automated synthesis of [18F]DCFPyL via direct radiofluorination and validation in preclinical prostate cancer models

TL;DR: An automated synthesis of [18F]DCFPyL via direct radiofluorination and validation in preclinical models of prostate cancer confirmed high PSMA-mediated tumor uptake combined with superior clearance parameters and points to a two-step molecular trapping mechanism based on PSMA binding and subsequent internalization leading to retention of radioactivity in PSMA+ LNCaP tumors.
Journal ArticleDOI

Copper-free click chemistry with the short-lived positron emitter fluorine-18

TL;DR: Copper-free strain-promoted click chemistry between (18)F-labeled aza-dibenzocyclooctyne [(18]F]FB-DBCO and various azides showed promising radiopharmacological profil with fast blood clearance as assessed with dynamic small animal PET studies.
Journal ArticleDOI

Biodistribution and uptake of 3'-deoxy-3'-fluorothymidine in ENT1-knockout mice and in an ENT1-knockdown tumor model.

TL;DR: Loss of ENT1 activity significantly affected 18F-FLT biodistribution in mice and 18F -FLT uptake in xenograft tumors, suggesting that nucleoside transporters are important mediators of 18F+/− uptake in normal and transformed cells.
Journal ArticleDOI

Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer

TL;DR: 6-deoxy-6-fluoro-d-fructose had a 10-fold higher potency than fructose to inhibit 6-[(18)F]FDF uptake into EMT-6 cells, respectively, and may represent a novel radiotracer for PET imaging of GLUT5 and ketohexokinase-expressing tumors.